Q1 2025 Earnings Conference Call April 29, 2025 6:45 AM ETCompany ParticipantsAndy Barnett - Head of IRPascal Soriot ...

GSK's severe asthma therapy Nucala could find a new ... METREX involved patients with a range of eosinophil levels and showed a statistically significant improvement for Nucala versus placebo ...

Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch and ...

Fasenra is already approved as an add-on maintenance treatment for severe eosinophilic asthma, making $1.3 billion ... which is approved for a range of inflammatory indications including atopic ...

Gene sequencing enabled researchers to identify the specific milk protein that triggered a patient’s eosinophilic esophagitis ...

Inhaled corticosteroid use in the afternoon vs morning was associated with better overnight lung function in atopic asthma.

The FDA has granted Orphan Drug designation to NS-229 for the treatment of eosinophilic granulomatosis with polyangiitis.

Routine Asthma Test More Reliable in the Morning ... study has identified one of the allergens responsible for eosinophilic esophagitis (EoE), an inflammatory disease of the esophagus.

Academics, led by experts from the University of Manchester, found that if a person with asthma takes their brown ... regime appeared to have better blood eosinophil counts – a key biomarker ...

The researchers compared asthma control and health care utilization one year before and one year after SBAT enrollment. HealthDay News — School-based asthma therapy (SBAT) can help improve ...

Gov. Maura Healey said the Trump administration terminated just under $1 million in grant dollars promised to the state to address asthma in Western Massachusetts, a move the governor argued ...